UB Paderborn / Katalog / Suche / in CDI

The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC

European journal of pharmaceutical sciences, 2014-06, Vol.57, p.152-163

2014

Volltextzugriff (PDF)

Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State

Molecular pharmaceutics, 2014-09, Vol.11 (9), p.3039-3047

2014

Volltextzugriff (PDF)

Evaluation of a Three Compartment In Vitro Gastrointestinal Simulator Dissolution Apparatus to Predict In Vivo Dissolution

Journal of pharmaceutical sciences, 2014-11, Vol.103 (11), p.3416-3422

2014

Volltextzugriff (PDF)

In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases

Journal of pharmaceutical sciences, 2015-09, Vol.104 (9), p.2894-2904

2015

Volltextzugriff (PDF)

The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene

Journal of pharmaceutical sciences, 2018-01, Vol.107 (1), p.307-316

2018

Volltextzugriff (PDF)

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

The AAPS journal, 2009-12, Vol.11 (4), p.740-746

2009

Volltextzugriff (PDF)

In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib

European journal of pharmaceutical sciences, 2015-08, Vol.76, p.203-212

2015

Volltextzugriff (PDF)

In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug–Drug Interaction Caused by Acid-Reducing Agents

Molecular pharmaceutics, 2015-07, Vol.12 (7), p.2418-2428

2015

Volltextzugriff (PDF)

The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone

Journal of pharmaceutical sciences, 2010-06, Vol.99 (6), p.2739-2749

2010

Volltextzugriff (PDF)

G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS

The AAPS journal, 2014-09, Vol.16 (5), p.894-898

2014

Volltextzugriff (PDF)

Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs

Molecular pharmaceutics, 2017-12, Vol.14 (12), p.4281-4294

2017

Volltextzugriff (PDF)

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Molecular pharmaceutics, 2011-10, Vol.8 (5), p.1848-1856

2011

Volltextzugriff (PDF)

Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting

American journal of physiology: Gastrointestinal and liver physiology, 2009-08, Vol.297 (2), p.G371-G377

2009

Volltextzugriff (PDF)

Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs

Molecular pharmaceutics, 2009-02, Vol.6 (1), p.19-28

2009

Volltextzugriff (PDF)

A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan

Molecular pharmaceutics, 2006-11, Vol.3 (6), p.631-643

2006

Volltextzugriff (PDF)

Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity

Biopharmaceutics & drug disposition, 2012-10, Vol.33 (7), p.403-416

2012

Volltextzugriff (PDF)

Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate–CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance

Molecular pharmaceutics, 2018-11, Vol.15 (11), p.5291-5301

2018

Volltextzugriff (PDF)

Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein

Pharmaceutical research, 2009-04, Vol.26 (4), p.883-892

2009

Volltextzugriff (PDF)

The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS)

European journal of pharmaceutical sciences, 2017-05, Vol.102, p.126-139

2017

Volltextzugriff (PDF)

Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine

Drug metabolism and disposition, 2009-10, Vol.37 (10), p.2028

2009

Volltextzugriff (PDF)

Gastrointestinal Motility Variation and Implications for Plasma Level Variation: Oral Drug Products

Molecular pharmaceutics, 2016-02, Vol.13 (2), p.557-567

2016

Volltextzugriff (PDF)

A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP

Pharmaceutics, 2020-01, Vol.12 (1), p.74

2020

Volltextzugriff (PDF)

The Biowaiver Extension for BCS Class III Drugs: The Effect of Dissolution Rate on the Bioequivalence of BCS Class III Immediate-Release Drugs Predicted by Computer Simulation

Molecular pharmaceutics, 2010-08, Vol.7 (4), p.1235-1243

2010

Volltextzugriff (PDF)

Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach

European journal of pharmaceutics and biopharmaceutics, 2018-08, Vol.129, p.162-174

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC

Quantification of Gastrointestinal Liquid Volumes and Distribution Following a 240 mL Dose of Water in the Fasted State

Evaluation of a Three Compartment In Vitro Gastrointestinal Simulator Dissolution Apparatus to Predict In Vivo Dissolution

In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases

The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene

Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs

In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib

In Vitro Dissolution of Fluconazole and Dipyridamole in Gastrointestinal Simulator (GIS), Predicting in Vivo Dissolution and Drug–Drug Interaction Caused by Acid-Reducing Agents

The Solubility–Permeability Interplay in Using Cyclodextrins as Pharmaceutical Solubilizers: Mechanistic Modeling and Application to Progesterone

G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS

Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs

Measurement of fasted state gastric antral motility before and after a standard bioavailability and bioequivalence 240 mL drink of water: Validation of MRI method against concomitant perfused manometry in healthy participants

The Solubility–Permeability Interplay: Mechanistic Modeling and Predictive Application of the Impact of Micellar Solubilization on Intestinal Permeation

Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting

Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs

A Provisional Biopharmaceutical Classification of the Top 200 Oral Drug Products in the United States, Great Britain, Spain, and Japan

Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity

Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate–CO2 Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical Significance

Grapefruit Juice and its Constituents Augment Colchicine Intestinal Absorption: Potential Hazardous Interaction and the Role of P-Glycoprotein

The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS)

Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine

Gastrointestinal Motility Variation and Implications for Plasma Level Variation: Oral Drug Products

A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP

The Biowaiver Extension for BCS Class III Drugs: The Effect of Dissolution Rate on the Bioequivalence of BCS Class III Immediate-Release Drugs Predicted by Computer Simulation

Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach

Suchergebnisse filtern